Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MultiCell Technologies Inc (EM) MCET

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc....


EXPM:MCET - Post by User

User Avatar Image
(0)
•••
  • MCETDREAMERX
Post by MCETDREAMERon Jun 29, 2021 10:01pm
134 Views
Post# 33471178

Corporations Infringing on Multicell Technology Inc.

Corporations Infringing on Multicell Technology Inc.There are more Corporations Infringing on the Fa N2-4 immortalized Human Hepatocytes Cell Lines. This information doesn't include any of the MCT family of drugs lines. This also should get investigated. 1) Multicell Technology Inc (401) 762-0045 68 Cumberland Street Suite 301 Woonsocket, RI 02895 United States www.multicelltech.com g.co 1) (JCRB) JCRB Cell Bank Flow of distribution of cells User login Q&A Contact Us Quality control of cell lines Link National Institutes of Biomedical Innovation, Health and Nutrition National Institute of Health Sciences Genome Medicine Database of Japan:GeMDBJ Contact UsPrivacy Policy JCRB Cell Bank (Japanese Collection of Research Bioresources Cell Bank) Cell Engineering Division / RIKEN BioResource Research Center 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan Fax:+81 29 836 9130 E-mail:cellbank.brc@riken.jp Copyright 2021 Cell Engineering Division -CELL BANK- - All Rights Reserved Link cellbank.nibiohn.go.jp Link American Type Culture Collection (ATCC, USA) Deutschen Sammlung von Mikroorganismen und Zellkulfuren(DSMZ) (Germany) European Collection of Cell Cultures (ECACC, UK) CellBank Australia (CBA, Australia) RIKEN Bioresource Center CELL BANK (Japan) International Cell Line Authentication Committee (ICLAC) 3) Sekisui XenoTech +1 913-438-7450 1101 W Cambridge Cir Dr, Kansas City, KS 66103 Website: XenoTech.com Sekisui XenoTech has world wide distributors. Please see Website. 4) Sekisui Headquarters. Osaka Head Office 2-4-4 Nishitemma, Kita-ku, Osaka 530-8565 Japan Map Tokyo Head Office 2-10-4 Toranomon, Minato-ku, Tokyo 105-8566 Japan Tel: +81-3-6748-6460 (Sekisui owns Sekisui XenoTech) Please see 3. 4) Sartorius Corporate Administration GmbH Otto-Brenner-Strae 20 37079 Goettingen Germany Phone: +49.551.308.0 Fax: +49.551.308.3289 Email: info@sartorius.com 5) Aragen GVN bio company aragenbio.com Headquarters 380 Woodview Avenue Morgan Hill, CA 95037 Phone: 408.549.9200 Fax: 408.779.1711 6) GeneCopoeia Contacts Emails: Product Inquiries & Price Quotes: inquiry@genecopoeia.com New Orders & Sales: sales@genecopoeia.com (For more information about how to order, please click here). Technical Support: support@genecopoeia.com Order Status, Shipping, & Datasheets: orders@genecopoeia.com Phone: 1-301-762-0888 Fax: 1-301-762-3888 Address: 9620 Medical Center Dr. Suite 101 Rockville, MD 20850 USA Worldwide Distributors: Check them out here 7) fyonibio service branch of Glycosylation is dependent on the host cell line. FyoniBio provides cell line development service using its human GlycoExpress (GEX) cell lines as well as its CHO platform technology CHOnamite. Glycotope GmbH Robert-Roessle-Str. 10 13125 Berlin Germany E / contact@fyonibio.com T / +49 (0) 30 9489 2600 CONTACT Dr. Doreen Weigelt t: +49 (0)30 9489 2600 e: contact@fyonibio.com 8) Takara Bio/Clontech/ Cellartis Shiga, Japan takaera.com 9) Cell Engineering Division / RIKEN BioResource Research Center 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan Fax:+81 29 836 9130 E-mail:cellbank.brc@riken.jp Copyright 2021 Cell Engineering Division -CELL BANK- - All Rights Reserved
<< Previous
Bullboard Posts
Next >>